theceomagazine.com | 161
Interview | INVEST
I
t takes a special kind of motivation to work in the
same field for 26 years. Fortunately for Raymond
Wong, General Manager of Takeda Pharmaceuticals
Hong Kong, he’s carried a keen sense of purpose
throughout the two and a half decades he’s spent in
the pharmaceutical industry.
For Raymond, it’s all about how much it means
to the patients that pharmaceutical companies deliver
their products to. Takeda, as an international company,
has been committed to serving the global community
through healthcare solutions, from prevention to care and
cure. Oncology, for example, is a crucial area, given that
it can be a life-or-death field. “We focused on increasing
the access to some of our ‘best in class’ oncology
medicine to patients. By doing so, Takeda aspires to
achieve the greatest possible health impact for patients
in a sustainable way in parts of the world with high
unmet needs,” says Raymond.
“We’re running a pharmaceutical business, but we
have to put the patient at the centre of everything we
do,” he says. “We have to find the most innovative way
to serve our patients so as to build their trust and
improve their lives. We believe if we do that, we have »
TAKEDA PHARMACEUTICALS
GENERAL MANAGER
RAYMOND WONG IS DRIVEN
TO PROVIDE HEALTHCARE
PRODUCTS TO THOSE IN NEED.
WORDS OLIVER FEATHERSTON • IMAGES GARETH BROWN
A culture
of health
“ WE HAVE T O FIND
THE MOST INNOVATIVE
WAY TO SERVE
OUR PATIENTS SO
AS TO BUILD THEIR
TRUST AND IMPROVE
THEIR LIVES.”